Prescribing the oral contraceptive pill: key considerations for primary care physicians.
OA: closed
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
- Efficacy and Safety of Estradiol Valerate/Dienogest for the Management of Heavy Menstrual Bleeding: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase III Clinical Trial 2018
- 20 µg versus >20 µg estrogen combined oral contraceptives for contraception. 2013
- Effects of continuous versus cyclical oral contraception: a randomized controlled trial. 2008
References (5)
- 20 µg versus >20 µg estrogen combined oral contraceptives for contraception. via crossref
- Effects of continuous versus cyclical oral contraception: a randomized controlled trial. via crossref
- Efficacy and Safety of Estradiol Valerate/Dienogest for the Management of Heavy Menstrual Bleeding: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase III Clinical Trial via crossref
- doi:10.1080/13697130500148875 via crossref
- doi:10.1576/toag.8.4.229.27272 via crossref
Source provenance
- crossref
- last seen: 2026-08-20T06:29:59.551719+00:00
- europepmc
- last seen: 2026-08-23T09:30:01.253652+00:00
- unpaywall
- last seen: 2026-08-25T06:41:39.333708+00:00